Evidence map›Paper›PMID 32055117›Full record

ArticleAnnals of Indian Academy of Neurology

Apomorphine: The Initial Indian Experience in Relation to Response Tests and Pumps.

L K Prashanth, R Jaychandran, Raghavendra Seetharam, Rajesh B Iyer

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of Indian Academy of Neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Excessive Daytime Sleepiness in Parkinson's Disease.Nature and science of sleep · 2022
    Review
  4. Looking Beyond the Fog-Apomorphine Demystified.Annals of Indian Academy of Neurology
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

L K PrashanthCenter for Parkinson's Disease and Movement Disorders Clinic, Bengaluru, Karnataka, India.
R JaychandranDepartment of Neurology, Institute of Neurosciences, Vikram Hospitals, Bengaluru, Karnataka, India.
Raghavendra SeetharamDepartment of Neurology, Institute of Neurosciences, Vikram Hospitals, Bengaluru, Karnataka, India.
Rajesh B IyerDepartment of Neurology, Institute of Neurosciences, Vikram Hospitals, Bengaluru, Karnataka, India.
Vikram Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundApomorphine is an option for continuous dopaminergic therapy in Parkinson's disease (PD). However, its effects in varied populations are limited due to its availability.

objectiveTo assess the efficacy and outcomes of apomorphine in Indian patients. MATERIALS AND

methodsRetrospective analysis of PD patients who underwent apomorphine response test (ART), along with the subset, who went on to apomorphine pumps.

resultsTwenty-nine confirmed PD patients underwent ART and all PD patients showed good clinical response. 19 subjects developed adverse events which included: nausea (

conclusionsApomorphine adds up to the armamentarium for treatment of PD patients in India with good clinical responses.

Indexed as

Adverse effectsapomorphine pumpsapomorphine response testIndia

Identifiers

PMID32055117
PMCPMC7001430
OpenAlexW2995716230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.